Physician profile
Lisa Marie Rullie
NPI 1649523523
$815.94
in general payments reported to CMS, 2019-2025
11 companies · $24.59 in 2025
The $24.59 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Family provider received nationally (typical 2025 total: $178).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $90.98 · 2023: $386 · 2024: $314 · 2025: $24.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.96 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $207.27 | 2022-2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $53.92 | 2023-2024 | Trintellix |
| Lundbeck LLC | $52.36 | 2022-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $43.60 | 2023-2024 | Rexulti, Abilify Maintena |
| Vertical Pharmaceuticals, LLC | $41.51 | 2024 | Relexxii |
| Corium, LLC | $40.50 | 2022-2023 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $34.07 | 2024 | Cobenfy |
| Axsome Therapeutics, INC. | $24.59 | 2025 | Auvelity |
| Alkermes, INC. | $23.16 | 2023 | Vivitrol |
| Tris Pharma INC | $18.00 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Rullie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.